News

pharmaphorum6d
Rexulti backed for Alzheimer’s agitation by FDA adcomm
Otsuka and Lundbeck’s antidepressant Rexulti should be approved to treat ... which already has an FDA green light for its Igalmi (dexmedetomidine) drug in agitation associated with schizophrenia ...
pharmaphorum2d
FDA clears Rexulti as first drug for Alzheimer’s agitation
Lundbeck and Otsuka’s Rexulti has become the first drug to be ... BioXcel Therapeutics already has an FDA green light for Igalmi (dexmedetomidine) in agitation associated with schizophrenia ...